Hepoxilin A3 facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers

Journal of Immunology

Volumn 189, Issue 10, 2012, Pages 4960-4969

  Tamang, David L ^a,b   Pirzai, Waheed ^a   Priebe, Gregory P ^c   Traficante, David C ^c   Pier, Gerald B ^c   Falck, John R ^d   Morisseau, Christophe ^e   Hammock, Bruce D ^e   McCormick, Beth A ^f   Gronert, Karsten ^g   Hurley, Bryan P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPOXILIN A; LIPOXYGENASE; PHOSPHOLIPASE A2;

ALOX 12 GENE; ALOX 12B GENE; ALOX 152 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; ELOX3 GENE; GADPH GENE; GENE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ALVEOLUS CELL CARCINOMA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSEUDOMONAS PNEUMONIA; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; UPREGULATION;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; BLOOD-AIR BARRIER; EPITHELIAL CELLS; FEMALE; HUMANS; MALE; MICE; NEUTROPHILS; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84868570916     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201922     Document Type: Article

References (67)

1. DeLeo, F. R., and H. F. Chambers. 2009. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 119: 2464-2474.
2. Mizgerd, J. P. 2006. Lung infection\a public health priority. PLoS Med. 3: e76.
3. McIntosh, K. 2002. Community-acquired pneumonia in children. N. Engl. J. Med. 346: 429-437.
4. Restrepo, M. I., and A. Anzueto. 2009. The role of gram-negative bacteria in healthcare-associated pneumonia. Semin. Respir. Crit. Care Med. 30: 61-66.
5. Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365-376.
6. Burns, A. R., C. W. Smith, and D. C. Walker. 2003. Unique structural features that influence neutrophil emigration into the lung. Physiol. Rev. 83: 309-336.
7. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15: 194-222.
8. Macdowell, A. L., and S. P. Peters. 2007. Neutrophils in asthma. Curr. Allergy Asthma Rep. 7: 464-468.
9. McDonald, B., K. Pittman, G. B. Menezes, S. A. Hirota, I. Slaba, C. C. Waterhouse, P. L. Beck, D. A. Muruve, and P. Kubes. 2010. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362-366.
10. Sanz, M. J., and P. Kubes. 2012. Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking. Eur. J. Immunol. 42: 278-283.
11. Hurley, B. P., W. Pirzai, K. L. Mumy, K. Gronert, and B. A. McCormick. 2011. Selective eicosanoid-generating capacity of cytoplasmic phospholipase A2 in Pseudomonas aeruginosa-infected epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L286-L294.
12. Hurley, B. P., D. Siccardi, R. J. Mrsny, and B. A. McCormick. 2004. Polymor-phonuclear cell transmigration induced by Pseudomonas aeruginosa requires the eicosanoid hepoxilin A3. J. Immunol. 173: 5712-5720.
13. Hurley, B. P., A. Sin, and B. A. McCormick. 2008. Adhesion molecules involved in hepoxilin A3-mediated neutrophil transepithelial migration. Clin. Exp. Immunol. 151: 297-305.
14. Hurley, B. P., N. L. Williams, and B. A. McCormick. 2006. Involvement of phospholipase A2 in Pseudomonas aeruginosa-mediated PMN transepithelial migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L703-L709.
15. Mrsny, R. J., A. T. Gewirtz, D. Siccardi, T. Savidge, B. P. Hurley, J. L. Madara, and B. A. McCormick. 2004. Identification of hepoxilin A3 in inflammatory events: a required role in neutrophil migration across intestinal epithelia. Proc. Natl. Acad. Sci. USA 101: 7421-7426.
16. Pace-Asciak, C. R., D. Reynaud, P. Demin, and S. Nigam. 1999. The hepoxilins. A review. Adv. Exp. Med. Biol. 447: 123-132.
17. Sutherland, M., T. Schewe, and S. Nigam. 2000. Biological actions of the free acid of hepoxilin A3 on human neutrophils. Biochem. Pharmacol. 59: 435-440.
18. Serhan, C. N., N. Chiang, and T. E. Van Dyke. 2008. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8: 349-361.
19. Dobrian, A. D., D. C. Lieb, B. K. Cole, D. A. Taylor-Fishwick, S. K. Chakrabarti, and J. L. Nadler. 2011. Functional and pathological roles of the 12-and 15-lipoxygenases. Prog. Lipid Res. 50: 115-131.
20. Nigam, S., S. Patabhiraman, R. Ciccoli, G. Ishdorj, K. Schwarz, B. Petrucev, H. Kühn, and J. Z. Haeggström. 2004. The rat leukocyte-type 12-lipoxygenase exhibits an intrinsic hepoxilin A3 synthase activity. J. Biol. Chem. 279: 29023-29030.
21. Yoshimoto, T., and Y. Takahashi. 2002. Arachidonate 12-lipoxygenases. Pros-taglandins Other Lipid Mediat. 68-69: 245-262.
22. Yu, Z., C. Schneider, W. E. Boeglin, L. J. Marnett, and A. R. Brash. 2003. The lipoxygenase gene ALOXE3 implicated in skin differentiation encodes a hy-droperoxide isomerase. Proc. Natl. Acad. Sci. USA 100: 9162-9167.
23. Yu, Z., C. Schneider, W. E. Boeglin, and A. R. Brash. 2005. Mutations associated with a congenital form of ichthyosis (NCIE) inactivate the epidermal lip-oxygenases 12R-LOX and eLOX3. Biochim. Biophys. Acta 3: 238-247.
24. Kuhn, H., M. Walther, and R. J. Kuban. 2002. Mammalian arachidonate 15-lipoxygenases structure, function, and biological implications. Prostaglandins Other Lipid Mediat. 68-69: 263-290.
25. McDonnell, M., H. Li, and C. D. Funk. 2002. Characterization of epidermal 12 (S) and 12(R) lipoxygenases. Adv. Exp. Med. Biol. 507: 147-153.
26. McCormick, B. A., P. M. Hofman, J. Kim, D. K. Carnes, S. I. Miller, and J. L. Madara. 1995. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neu-trophils. J. Cell Biol. 131: 1599-1608.
27. Leedom, A. J., A. B. Sullivan, B. Dong, D. Lau, and K. Gronert. 2010. Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury. Am. J. Pathol. 176: 74-84.
28. Shahabi, S., Z. M. Hassan, and N. H. Jazani. 2009. Post heat shock tolerance: a neuroimmunological anti-inflammatory phenomenon. J. Inflamm. (Lond.) 6: 7.
29. Morisseau, C., and B. D. Hammock. 2005. Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu. Rev. Pharmacol. Toxicol. 45: 311-333.
30. Newman, J. W., C. Morisseau, T. R. Harris, and B. D. Hammock. 2003. The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc. Natl. Acad. Sci. USA 100: 1558-1563.
31. Wang, S. B., K. M. Hu, K. J. Seamon, V. Mani, Y. Chen, and K. Gronert. 2012. Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the cornea. FASEB J. 26: 1506-1516.
32. Priebe, G. P., G. J. Meluleni, F. T. Coleman, J. B. Goldberg, and G. B. Pier. 2003. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect. Immun. 71: 1453-1461.
33. Priebe, G. P., R. L. Walsh, T. A. Cederroth, A. Kamei, Y. S. Coutinho-Sledge, J. B. Goldberg, and G. B. Pier. 2008. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa. J. Immunol. 181: 4965-4975.
34. Funk, C. D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
35. Vancheri, C., C. Mastruzzo, M. A. Sortino, and N. Crimi. 2004. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol. 25: 40-46.
36. Burgoyne, R. D., and A. Morgan. 1990. The control of free arachidonic acid levels. Trends Biochem. Sci. 15: 365-366.
37. Cho, H., M. Ueda, M. Tamaoka, M. Hamaguchi, K. Aisaka, Y. Kiso, T. Inoue, R. Ogino, T. Tatsuoka, T. Ishihara, et al. 1991. Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase. J. Med. Chem. 34: 1503-1505.
38. Kurosawa, M., T. Hisada, and T. Ishizuka. 1992. Effect of phospholipase A2 inhibitor ONO-RS-082 on substance P-induced histamine release from rat peritoneal mast cells. Int. Arch. Allergy Immunol. 97: 226-228.
39. Hurley, B. P., and B. A. McCormick. 2008. Multiple roles of phospholipase A2 during lung infection and inflammation. Infect. Immun. 76: 2259-2272.
40. Murakami, M., and I. Kudo. 2002. Phospholipase A2. J. Biochem. 131: 285-292.
41. Cronin, A., M. Decker, and M. Arand. 2011. Mammalian soluble epoxide hy-drolase is identical to liver hepoxilin hydrolase. J Lipid Res. 52: 712-719.
42. Pace-Asciak, C. R., D. Reynaud, O. Rounova, P. Demin, and K. K. Pivnitsky. 1999. Hepoxilin A3 is metabolized into its omega-hydroxy metabolite by human neutrophils. Adv. Exp. Med. Biol. 469: 535-538.
43. Reynaud, D., and C. R. Pace-Asciak. 1997. Docosahexaenoic acid causes accumulation of free arachidonic acid in rat pineal gland and hippocampus to form hepoxilins from both substrates. Biochim. Biophys. Acta 1346: 305-316.
44. Power, M. R., Y. Peng, E. Maydanski, J. S. Marshall, and T. J. Lin. 2004. The development of early host response to Pseudomonas aeruginosa lung infection is critically dependent on myeloid differentiation factor 88 in mice. J. Biol. Chem. 279: 49315-49322.
45. Prince, A. S., J. P. Mizgerd, J. Wiener-Kronish, and J. Bhattacharya. 2006. Cell signaling underlying the pathophysiology of pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 291: L297-L300.
46. Qin, L., W. M. Quinlan, N. A. Doyle, L. Graham, J. E. Sligh, F. Takei, A. L. Beaudet, and C. M. Doerschuk. 1996. The roles of CD11/CD18 and ICAM-1 in acute Pseudomonas aeruginosa-induced pneumonia in mice. J. Immunol. 157: 5016-5021.
47. Sadikot, R. T., H. Zeng, M. Joo, M. B. Everhart, T. P. Sherrill, B. Li, D. S. Cheng, F. E. Yull, J. W. Christman, and T. S. Blackwell. 2006. Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa. J. Immunol. 176: 4923-4930.
48. Schultz, M. J., A. W. Rijneveld, S. Florquin, C. K. Edwards, C. A. Dinarello, and T. van der Poll. 2002. Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 282: L285-L290.
49. Skerrett, S. J., H. D. Liggitt, A. M. Hajjar, and C. B. Wilson. 2004. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J. Immunol. 172: 3377-3381.
50. Skerrett, S. J., C. B. Wilson, H. D. Liggitt, and A. M. Hajjar. 2007. Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L312-L322.
51. Sun, L., R. F. Guo, M. W. Newstead, T. J. Standiford, D. R. Macariola, and T. P. Shanley. 2009. Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge. Am. J. Respir. Cell Mol. Biol. 41: 76-84.
52. Koh, A. Y., G. P. Priebe, C. Ray, N. Van Rooijen, and G. B. Pier. 2009. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect. Immun. 77: 5300-5310.
53. Chen, S. M., D. S. Cheng, B. J. Williams, T. P. Sherrill, W. Han, M. Chont, L. Saint-Jean, J. W. Christman, R. T. Sadikot, F. E. Yull, and T. S. Blackwell. 2008. The nuclear factor kappa-B pathway in airway epithelium regulates neu-trophil recruitment and host defence following Pseudomonas aeruginosa infection. Clin. Exp. Immunol. 153: 420-428.
54. Rollins, B. J. 2009. Where the confusion began: cloning the first chemokine receptors. J. Immunol. 183: 2893-2894.
55. Chun, J., and A. Prince. 2009. Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration. J. Leukoc. Biol. 86: 1135-1144.
56. Craig, A., J. Mai, S. Cai, and S. Jeyaseelan. 2009. Neutrophil recruitment to the lungs during bacterial pneumonia. Infect. Immun. 77: 568-575.
57. Stillie, R., S. M. Farooq, J. R. Gordon, and A. W. Stadnyk. 2009. The functional significance behind expressing two IL-8 receptor types on PMN. J. Leukoc. Biol. 86: 529-543.
58. Weathington, N. M., A. H. van Houwelingen, B. D. Noerager, P. L. Jackson, A. D. Kraneveld, F. S. Galin, G. Folkerts, F. P. Nijkamp, and J. E. Blalock. 2006. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12: 317-323.
59. Farberman, M. M., A. Ibricevic, T. D. Joseph, K. T. Akers, R. Garcia-Medina, S. Crosby, L. L. Clarke, S. L. Brody, and T. W. Ferkol. 2011. Effect of polarized release of CXC-chemokines from wild-type and cystic fibrosis murine airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 45: 221-228.
60. McCormick, B. A. 2007. Bacterial-induced hepoxilin A3 secretion as a pro-inflammatory mediator. FEBS J. 274: 3513-3518.
61. Mizgerd, J. P., and S. J. Skerrett. 2008. Animal models of human pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L387-L398.
62. Bodini, A., C. D'Orazio, D. Peroni, M. Corradi, G. Folesani, E. Baraldi, B. M. Assael, A. Boner, and G. L. Piacentini. 2005. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Pediatr. Pulmonol. 40: 494-499.
63. Mackerness, K. J., G. R. Jenkins, A. Bush, and P. J. Jose. 2008. Characterisation of the range of neutrophil stimulating mediators in cystic fibrosis sputum. Thorax 63: 614-620.
64. Funk, C. D., X. S. Chen, E. N. Johnson, and L. Zhao. 2002. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat. 68-69: 303-312.
65. Yoshikai, Y. 2001. Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection. Curr. Opin. Infect. Dis. 14: 257-263.
66. Berger, W., M. T. De Chandt, and C. B. Cairns. 2007. Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease. Int. J. Clin. Pract. 61: 663-676.
67. Konstan, M. W. 2008. Ibuprofen therapy for cystic fibrosis lung disease: revisited. Curr. Opin. Pulm. Med. 14: 567-573.